|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.820 CNY | -0.21% |
|
+3.21% | -12.84% |
| 05-25 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 04-24 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 8.27B 1.22B 1.06B 991M 909M 1.72B 117B 1.74B 11.68B 4.58B 58.18B 4.6B 4.5B 195B | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94B 2.66B 2.31B 2.15B 1.97B 3.73B 254B 3.78B 25.34B 9.94B 126B 9.98B 9.76B 423B | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.58% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | -0.21% | ||
| 1 week | +3.21% | ||
| 1 month | +12.88% | ||
| 3 months | -7.49% | ||
| 6 months | -14.99% | ||
| Current year | -12.84% |
| 1 week | 4.65 |  | 4.88 |
| 1 month | 4.41 | | 5.08 |
| Current year | 4.11 | | 6.07 |
| 1 year | 4.11 | | 7.12 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
Ya Lou Wang
BRD | Director/Board Member | 54 | 12/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/02/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | +3.21% | -29.94% | -16.61% | 1.22B | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | |
| Average | -1.26% | -0.97% | +24.11% | +43.12% | 357.5B | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.22% | +72.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.87B 1.46B 1.27B 1.18B 1.09B 2.05B 139B 2.08B 13.94B 5.47B 69.44B 5.49B 5.37B 233B | 9.24B 1.37B 1.19B 1.11B 1.02B 1.92B 131B 1.95B 13.05B 5.12B 65.02B 5.14B 5.03B 218B |
| Net income | 127M 18.8M 16.34M 15.21M 13.97M 26.37M 1.79B 26.78M 179M 70.37M 893M 70.61M 69.06M 3B | 183M 27.1M 23.56M 21.93M 20.13M 38.02M 2.59B 38.61M 258M 101M 1.29B 102M 99.54M 4.32B |
| Net Debt | 9.79B 1.45B 1.26B 1.17B 1.08B 2.03B 138B 2.06B 13.82B 5.42B 68.88B 5.44B 5.32B 231B | 9.67B 1.43B 1.24B 1.16B 1.06B 2.01B 137B 2.04B 13.66B 5.36B 68.06B 5.38B 5.26B 228B |
Employees
9,972
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CN¥4.820 | -0.21% | 15,092,125 |
| 30/07/26 | CN¥4.830 | +0.63% | 16,376,019 |
| 29/07/26 | CN¥4.800 | +0.84% | 15,225,700 |
| 28/07/26 | CN¥4.760 | -0.21% | 13,080,500 |
| 27/07/26 | CN¥4.770 | +2.14% | 16,376,630 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
